4058 related articles for article (PubMed ID: 6541367)
1. Determination of tissue plasminogen activator in plasma samples by means of a radioimmunoassay.
Urdén G; Blombäck M
Scand J Clin Lab Invest; 1984 Oct; 44(6):495-502. PubMed ID: 6541367
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of plasminogen activator in human plasma using the method of fibrin/celite column chromatography--with special reference to the determination of fibrin adsorbable tissue-plasminogen activator by ELISA].
Ieko M
Hokkaido Igaku Zasshi; 1985 Nov; 60(6):834-47. PubMed ID: 4085966
[TBL] [Abstract][Full Text] [Related]
3. Comparison of plasminogen activator inhibitor activity and antigen in plasma samples.
Urdén G; Hamsten A; Wiman B
Clin Chim Acta; 1987 Nov; 169(2-3):189-96. PubMed ID: 3501347
[TBL] [Abstract][Full Text] [Related]
4. The role of the fibrinolytic system in deep vein thrombosis.
Wiman B; Ljungberg B; Chmielewska J; Urdén G; Blombäck M; Johnsson H
J Lab Clin Med; 1985 Feb; 105(2):265-70. PubMed ID: 3919125
[TBL] [Abstract][Full Text] [Related]
5. A sensitive assay for tissue plasminogen activator activity in plasma, using adsorption on lysine-sepharose.
Gyzander E; Eriksson E; Teger-Nilsson AC
Thromb Res; 1984 Sep; 35(5):547-58. PubMed ID: 6541374
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator and plasminogen activator inhibitor activities in a reference population.
Krishnamurti C; Tang DB; Barr CF; Alving BM
Am J Clin Pathol; 1988 Jun; 89(6):747-52. PubMed ID: 3259399
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacology in patients with evolving myocardial infarction of tissue-type plasminogen activator produced by recombinant DNA technology.
Tiefenbrunn AJ; Robinson AK; Kurnik PB; Ludbrook PA; Sobel BE
Circulation; 1985 Jan; 71(1):110-6. PubMed ID: 4038368
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of von Willebrand factor and plasminogen activator in patients with arterial thromboembolism--with special reference to their correlation to the increased catabolism of both fibrinogen and platelets.
Matsumoto M; Uchiyama T; Kobayashi N; Maekawa T
Nihon Ketsueki Gakkai Zasshi; 1989 Sep; 52(6):1105-14. PubMed ID: 2588960
[TBL] [Abstract][Full Text] [Related]
9. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
10. Sandwich ELISA for t-PA antigen employing a monoclonal antibody.
Korninger C; Speiser W; Wojta J; Binder BR
Thromb Res; 1986 Feb; 41(4):527-35. PubMed ID: 3083527
[TBL] [Abstract][Full Text] [Related]
11. Sensitive and specific enzyme-linked immunosorbent assay for urokinase-type plasminogen activator and its application to plasma from patients with breast cancer.
Grøndahl-Hansen J; Agerlin N; Munkholm-Larsen P; Bach F; Nielsen LS; Dombernowsky P; Danø K
J Lab Clin Med; 1988 Jan; 111(1):42-51. PubMed ID: 3121772
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator release during venous stasis and exercise as determined by a new specific assay.
Wiman B; Mellbring G; Rånby M
Clin Chim Acta; 1983 Jan; 127(2):279-88. PubMed ID: 6218942
[TBL] [Abstract][Full Text] [Related]
13. A sensitive solid-phase immunosorbent assay for tissue-type plasminogen activator activity in plasma using trinitrobenzoylated poly-D-lysine as a stimulator for plasminogen activation.
Petersen LC; Handest P; Brender J; Selmer J; Jørgensen M; Thorsen S
Thromb Haemost; 1987 Apr; 57(2):205-11. PubMed ID: 3110997
[TBL] [Abstract][Full Text] [Related]
14. Determination of plasminogen activator inhibitor in plasma using t-PA and a chromogenic single-point poly-D-lysine stimulated assay.
Eriksson E; Rånby M; Gyzander E; Risberg B
Thromb Res; 1988 Apr; 50(1):91-101. PubMed ID: 3135638
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies.
Wojta J; Turcu L; Wagner OF; Korninger C; Binder BR
J Lab Clin Med; 1987 Jun; 109(6):665-71. PubMed ID: 3108431
[TBL] [Abstract][Full Text] [Related]
16. Potentiation by Lys-plasminogen of clot lysis by single or two chain urokinase-type plasminogen activator or tissue-type plasminogen activator.
Watahiki Y; Scully MF; Ellis V; Kakkar VV
Thromb Haemost; 1989 Jun; 61(3):502-6. PubMed ID: 2508259
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activators and plasminogen activator inhibitor 1 before and after venous occlusion of the upper limb in thromboangiitis obliterans (Buerger's disease).
Choudhury NA; Pietraszek MH; Hachiya T; Baba S; Sakaguchi S; Takada Y; Takada A
Thromb Res; 1992 May; 66(4):321-9. PubMed ID: 1412199
[TBL] [Abstract][Full Text] [Related]
18. Physical exercise induces enhancement of urokinase-type plasminogen activator (u-PA) levels in plasma.
Dooijewaard G; de Boer A; Turion PN; Cohen AF; Breimer DD; Kluft C
Thromb Haemost; 1991 Jan; 65(1):82-6. PubMed ID: 1902597
[TBL] [Abstract][Full Text] [Related]
19. Alterations in the fibrinolytic system components during acute myocardial infarction.
Ioannidou-Papayannaki E; Lefkos N; Boudonas G; Efthimiadis A; Psirropoulos D; Vogas V; Papadopoulos I; Klonizakis I
Acta Cardiol; 2000 Aug; 55(4):247-53. PubMed ID: 11041123
[TBL] [Abstract][Full Text] [Related]
20. Relationship between age and plasma t-PA, PA-inhibitor, and PA activity.
Hashimoto Y; Kobayashi A; Yamazaki N; Sugawara Y; Takada Y; Takada A
Thromb Res; 1987 Jun; 46(5):625-33. PubMed ID: 3114907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]